2025
|
Invention
|
Stat3 inhibitors for use in the treatment of cancer. Provided herein, in some embodiments, are me... |
2024
|
Invention
|
Solid-state forms of stat3 inhibitors and methods of use thereof. Provided herein, in some embodi... |
|
Invention
|
Formulations of stat3 inhibitors and methods of use thereof. Provided herein are methods of treat... |
|
Invention
|
Prodrugs of stat3 inhibitors.
Provided herein, in certain embodiments, are compounds of Formula ... |
2023
|
Invention
|
Stat3 inhibitors for use in the treatment of non-viral liver cancer. Provided herein, in some emb... |
|
Invention
|
Stat3 inhibitors.
Compounds as STAT3 inhibitors are described. A pharmaceutical composition comp... |
|
Invention
|
Therapeutic compounds, formulations, and use thereof.
The present disclosure, in part, is direct... |
|
Invention
|
Prodrugs of stat3 inhibitors. Provided herein, in certain embodiments, are compounds of Formula I... |
|
Invention
|
Therapeutic compounds, formulations, and use thereof. The present disclosure, in part, is directe... |
|
Invention
|
Therapeutic compounds, formulations, and use thereof |
|
Invention
|
Prodrugs of stat3 inhibitors. ((Formula I:) or a pharmaceutically acceptable salt or a solvate th... |
|
Invention
|
Prodrugs of stat3 inhibitors |
|
Invention
|
Combinations of stat-inhibitors and immune checkpoint inhibitors for the treatment and/or managem... |
|
Invention
|
Therapeutic compounds, formulations, and use thereof.
Provided herein are solid amorphous disper... |
|
Invention
|
Therapeutic compounds, formulations, and use thereof. Provided herein are solid amorphous dispers... |
2022
|
Invention
|
Therapeutic compounds, formulations, and uses thereof. Provided herein are compositions, formulat... |
|
P/S
|
Pharmaceutical preparations for treating cancer, inflammation and fibrosis; pharmaceutical and th... |
|
P/S
|
Pharmaceutical research and development services |
2021
|
P/S
|
Pharmaceutical preparations for treating cancer, inflammation and fibrosis |
2020
|
Invention
|
Therapeutic compounds for methods of use in insulin resistance.
Embodiments of the disclosure en... |
|
Invention
|
Therapeutic compounds for methods of use in insulin resistance. Embodiments of the disclosure enc... |
|
Invention
|
Stat3 inhibitors. Compounds as STAT3 inhibitors are described. A pharmaceutical composition compr... |
2018
|
P/S
|
Pharmaceutical preparations for treating cancer |